Skip to main content

INVESTING IN INNOVATION

Commercialising world class research from UCL

£0M

HAS been invested in UCL projects

0

Proof of concept investments

0

PORTFOLIO COMPANIES

0

Licensing projects

Intrinsic closes £1.35m seed funding round to prototype next generation memory devices

Why you should consider manufacturing from the start of the biotech R&D process

NovalGen enters strategic partnership with HALIX B.V. to manufacture clinical trial materials

NovalGen doses first patient in Phase I study in Chronic Lymphocytic Leukemia & Mantle Cell Lymphoma

UCL Technology Fund secures partnership with Viralgen, leading gene therapy manufacturer

Achilles Therapeutics Announces Pricing of Initial Public Offering